OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AIH$0.8158

Advanced Innergy Holdings Ltd

Specialty ChemicalsVerified

The company's capital structure is characterized by a debt-to-equity ratio of 1.12, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.28 and cash and equivalents of GBP 17.75 million. However, the company has GBP 78.57 million in long-term debt, and net cash is negative after subtracting total debt, which raises concerns about its short-term liquidity. Profitability metrics show a return on equity (ROE) of 15.08% and a return on assets (ROA) of 5.51%. These figures are above the typical thresholds for the specialty chemicals industry, suggesting that the company is generating strong returns relative to its equity and asset base. The gross profit margin is 36.34% (GBP 54.71 million gross profit on GBP 150.55 million revenue), and the operating margin is 12.01% (GBP 18.08 million operating income on GBP 150.55 million revenue), both of which are strong indicators of cost control and pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates. The company's growth trajectory is not clearly defined in the available data, as there are no forward-looking revenue projections or historical growth rates provided. However, the company's free cash flow of GBP 12.77 million and operating cash flow of GBP 24.57 million suggest that it has the capacity to fund operations and potentially invest in growth initiatives. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could limit its ability to meet short-term obligations without additional financing. No dilution adjustments are applied in the valuation, and the company's shares outstanding are the same for both basic and diluted calculations, indicating no imminent dilution pressure. Recent events and filings do not provide specific details on material developments, but the company's financial statements and analyst estimates suggest a generally positive outlook. Analysts have assigned a mean price target of GBP 1.45, with a strong buy recommendation, indicating confidence in the company's future performance.

30-day price · AIH(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAdvanced Innergy Holdings Ltd
TickerAIH.AX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Advanced Innergy Holdings Ltd (AIH.AX) is a specialty chemicals company that produces and sells chemical products, primarily generating revenue through the sale of these products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure is characterized by a debt-to-equity ratio of 1.12, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.28 and cash and equivalents of GBP 17.75 million. However, the company has GBP 78.57 million in long-term debt, and net cash is negative after subtracting total debt, which raises concerns about its short-term liquidity. Profitability metrics show a return on equity (ROE) of 15.08% and a return on assets (ROA) of 5.51%. These figures are above the typical thresholds for the specialty chemicals industry, suggesting that the company is generating strong returns relative to its equity and asset base. The gross profit margin is 36.34% (GBP 54.71 million gross profit on GBP 150.55 million revenue), and the operating margin is 12.01% (GBP 18.08 million operating income on GBP 150.55 million revenue), both of which are strong indicators of cost control and pricing power. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates. The company's growth trajectory is not clearly defined in the available data, as there are no forward-looking revenue projections or historical growth rates provided. However, the company's free cash flow of GBP 12.77 million and operating cash flow of GBP 24.57 million suggest that it has the capacity to fund operations and potentially invest in growth initiatives. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could limit its ability to meet short-term obligations without additional financing. No dilution adjustments are applied in the valuation, and the company's shares outstanding are the same for both basic and diluted calculations, indicating no imminent dilution pressure. Recent events and filings do not provide specific details on material developments, but the company's financial statements and analyst estimates suggest a generally positive outlook. Analysts have assigned a mean price target of GBP 1.45, with a strong buy recommendation, indicating confidence in the company's future performance.
Key takeaways
  • The company has a strong return on equity (15.08%) and return on assets (5.51%), indicating efficient use of capital and assets.
  • The company's liquidity position is medium, with a current ratio of 1.28 and a negative net cash position after subtracting total debt.
  • The company's profitability is supported by a high gross profit margin (36.34%) and a strong operating margin (12.01%).
  • The company's valuation multiples, including a price-to-earnings ratio of 32.31 and a price-to-book ratio of 4.87, suggest that it is trading at a premium relative to its book value and earnings.
  • Analysts have a positive outlook on the company, with a mean price target of GBP 1.45 and a strong buy recommendation.
  • # RATIONALES
  • **margin_outlook_rationale**: The company's gross and operating margins are strong, suggesting that it can maintain profitability if input costs remain stable.
  • **rd_outlook_rationale**: No specific R&D data is provided, but the company's operating cash flow suggests it has the financial capacity to invest in innovation.
Financial snapshot
PeriodHA-latest
CurrencyGBP
Revenue$150.5M
Gross profit$54.7M
Operating income$18.1M
Net income$10.6M
R&D
SG&A
D&A
SBC
Operating cash flow$24.6M
CapEx-$4.9M
Free cash flow$12.8M
Total assets$192.1M
Total liabilities$121.9M
Total equity$70.2M
Cash & equivalents$17.8M
Long-term debt$78.6M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$0.81
Market cap$342.1M
Enterprise value$402.9M
P/E32.3
Reported non-GAAP P/E
EV/Revenue2.7
EV/Op income22.3
EV/OCF16.4
P/B4.9
P/Tangible book4.9
Tangible book$70.2M
Net cash-$60.8M
Current ratio1.3
Debt/Equity1.1
ROA5.5%
ROE15.1%
Cash conversion2.3%
CapEx/Revenue-3.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricAIHActivity
Op margin12.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin7.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin36.3%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-3.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity112.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target1.45 GBP
Median price target1.45 GBP
High price target1.45 GBP
Low price target1.45 GBP
Mean recommendation1.00 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count0.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.07 GBP
Mean revenue estimate380,300,000 GBP
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 18:36 UTC#fc48e62f
Market quoteclose GBP 0.81 · shares 0.42B diluted
no public URL
2026-05-04 18:36 UTC#68f60ae9
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 18:37 UTCJob: 37a3f17c